Dr. Vladimir Shulaev Joins PREMIER Biosoft Scientific Advisory Board
News Sep 19, 2015
PREMIER Biosoft has announced that Dr. Vladimir Shulaev, PhD, has joined its Science Advisory Board (SAB) to assist the company in its efforts to develop software solutions to automate the mass spectrometry based metabolite and lipid profiling and quantitation methodologies.
In a statement, Chief Executive Officer at PREMIER Biosoft, Arun Apte said, "Dr. Vladimir's extraordinary accomplishment in developing metabolomics techniques and applying high-throughput metabolite profiling to study stress response in microorganisms, plants and animals brings immense value to our Scientific Advisory Board. We are delighted to have Dr. Valdimir on our panel."
Dr. Vladimir Shulaev has been actively working on cellular metabolites for the past 20 years. He is a Professor in the Department of Biological Sciences at the University of North Texas, TX. His main research interest is in developing metabolomics technology and contemplating the susceptibility of crops towards environmental stress - drought, high salinity and other climatic factors leading to reduced global agriculture productivity. He is formulating next generation breeding and engineering strategies aimed at reducing crop losses by unraveling the underlying plant metabolic responses to environmental stress.
"I am delighted to join the Scientific Advisory Board alongside an impressive group of industry peers,” said Dr. Shulaev. “I use the automated solutions PREMIER Biosoft has developed for small molecule research and see an enormous potential in their software products to take this research forward. I look forward to working with them to help advance small molecule research and to unravel the answers we have been seeking."
Dr. Shulaev joins the current members of the PREMIER Biosoft's Scientific Advisory Board which includes:
1. Dr. John E. Wiktorowicz
Professor of Biochemistry and Molecular Biology at the University of Texas Medical Branch in Galveston, Texas.
Director of the Proteomics Section of the Biomolecular Resource Facility at UTMB
Director of Innovative Technologies for the NHLBI Proteomics Center for Airway Inflammation, and Director of Discovery Proteomics for the NIAID Clinical Proteomics Center.
2. Dr. Michael Tiemeyer
Professor of Biochemistry and Molecular Biology, University of Georgia
Associate Director for Research at the Complex Carbohydrate Research Center (CCRC), University of Georgia.
3. Dr. Gregory Shipley
Former Director of the Quantitative Genomics Core Laboratory until he retired in 2012.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
World Congress on Plant Science and Molecular Biology
Sep 12 - Sep 13, 2018